For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human Dlx4 aa 200 to the C-terminus (Cysteine residue). The exact sequence is proprietary.
Database link: Q92988
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab175218 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ICC/IF||1/100 - 1/250.|
|IP||1/10 - 1/100.|
|IHC-P||1/100 - 1/250.|
|WB||1/1000 - 1/5000. Predicted molecular weight: 26 kDa.|
Immunohistochemical analysis of paraffin-embedded Human prostatic hyperplasia tissue labeling Dlx4 with ab175218 at 1/100 dilution.
Immunohistochemical analysis of paraffin-embedded Human placenta tissue labeling Dlx4 with ab175218 at 1/100 dilution.
Immunofluorescence analysis of SW480 cells labeling Dlx4 with ab175218 at 1/100 dilution.
Western blot analysis on immunoprecipitation pellet from K562 cell lysate using ab175218 at 1/10 dilution.
ab175218 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"